These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9346826)

  • 21. Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.
    Fouts DE; True HL; Cengel KA; Celander DW
    Biochemistry; 1997 Oct; 36(43):13256-62. PubMed ID: 9341215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroviruses as model systems for the study of nuclear RNA export pathways.
    Cullen BR
    Virology; 1998 Sep; 249(2):203-10. PubMed ID: 9791012
    [No Abstract]   [Full Text] [Related]  

  • 24. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
    Daelemans D; Afonina E; Nilsson J; Werner G; Kjems J; De Clercq E; Pavlakis GN; Vandamme AM
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14440-5. PubMed ID: 12374846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev.
    Zhang MJ; Dayton AI
    Biochem Biophys Res Commun; 1998 Feb; 243(1):113-6. PubMed ID: 9473489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rev protein suppression of complex formation between nuclear proteins and rev-responsive element-containing RNA of human immunodeficiency virus-1.
    Bek A; Müller WE; Sève AP; Kavsan V; Schröder HC
    Int J Biochem Cell Biol; 1995 Dec; 27(12):1317-29. PubMed ID: 8581828
    [No Abstract]   [Full Text] [Related]  

  • 27. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure of the HIV-1 RRE high affinity rev binding site at 1.6 A resolution.
    Ippolito JA; Steitz TA
    J Mol Biol; 2000 Jan; 295(4):711-7. PubMed ID: 10656783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression.
    Hariton-Gazal E; Rosenbluh J; Zakai N; Fridkin G; Brack-Werner R; Wolff H; Devaux C; Gilon C; Loyter A
    Biochemistry; 2005 Aug; 44(34):11555-66. PubMed ID: 16114892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific RNA binding proteins constructed from zinc fingers.
    Friesen WJ; Darby MK
    Nat Struct Biol; 1998 Jul; 5(7):543-6. PubMed ID: 9665165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
    Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.
    Lepage P; Heckel C; Humbert S; Stahl S; Rautmann G
    Anal Biochem; 1993 Aug; 213(1):40-8. PubMed ID: 8238880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1H NMR studies of the high-affinity Rev binding site of the Rev responsive element of HIV-1 mRNA: base pairing in the core binding element.
    Peterson RD; Bartel DP; Szostak JW; Horvath SJ; Feigon J
    Biochemistry; 1994 May; 33(18):5357-66. PubMed ID: 8180157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form.
    Blanco FJ; Hess S; Pannell LK; Rizzo NW; Tycko R
    J Mol Biol; 2001 Nov; 313(4):845-59. PubMed ID: 11697908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
    Pallesen J; Dong M; Besenbacher F; Kjems J
    FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct RNA binding by the rev product of HIV-1.
    Walley AJ; Heaphy S; Jones IM
    AIDS; 1989 Dec; 3(12):859-61. PubMed ID: 2517208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.